Skip to content
Brand AI

Galenica

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2012

    Competition investigation over pharmaceutical-information databases

    The Swiss Competition Commission opened proceedings involving Galenica subsidiaries Documed, e-mediat and HCI Solutions. The investigation concerned alleged abuse of a dominant position in medicine-information databases, including claims that companies were charged for access to pharmaceutical data and that smaller manufacturers faced threats of removal from systems used by hospitals and other institutions. The dispute also involved the development of alternative and open-access information platforms.

    Source